Allergan's sales rose by 9.0 percent to $1,365.7 million in...

Allergan's sales rose by 9.0 percent to $1,365.7 million in the first quarter, or by 10.4 percent in constant currencies. In particular, specialty pharmaceuticals went up by 10.8 percent in dollars and by 12.2 percent in local currencies.

You need to register to continue reading this article

Already subscribe to Eyewear intelligence? Sign in here

Register to continue reading

By registering today you will have access to:

  • 3 industry news articles per month

For full access and to receive in-depth news, analysis and more, become a member today

For more content and resources become a member? View our membership packages.